Internal Medicine, Nephrology · Orange, CA
NPI
1477623635
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
500 S Main St, Suite 101
Orange, CA, 92868
Phone (714) 836-4204
Groups this clinician bills Medicare through
Medicare paid, 2024
$560K
4,150 services
Medicare patients, 2024
814
Average age 74
Drug cost, 2024
$2.1M
7,059 prescriptions
Company payments, 2025
$4,143
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin Pham was code 99232 (hospital e&m - subsequent), 1,210 times for 256 patients. In total Kevin Pham billed 4,150 services in 22 codes, and Medicare paid $560K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-08-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,210 | 256 | $69.47 | $84K |
| 99213 Office E&M - Established | Office | 941 | 438 | $60.13 | $57K |
| 90960 ESRD Related Services (not dialysis) | Office | 692 | 98 | $317.84 | $220K |
| 90935 Hemodialysis | Facility | 306 | 92 | $62.77 | $19K |
| 99222 Hospital E&M - Initial | Facility | 195 | 133 | $114.95 | $22K |
| 90960 ESRD Related Services (not dialysis) | Facility | 150 | 29 | $316.13 | $47K |
| 90966 ESRD Related Services (not dialysis) | Office | 138 | 19 | $263.29 | $36K |
| 99204 Office E&M - New | Office | 108 | 108 | $148.47 | $16K |
| 99223 Hospital E&M - Initial | Facility | 103 | 101 | $151.51 | $16K |
| 90961 ESRD Related Services (not dialysis) | Office | 85 | 56 | $265.16 | $23K |
| 90945 Peritoneal Dialysis | Facility | 76 | 12 | $76.81 | $5,837 |
| 99442 Telephone Services | Office | 55 | 43 | $61.50 | $3,382 |
| 90961 ESRD Related Services (not dialysis) | Facility | 22 | 12 | $236.05 | $5,193 |
By year: 2022 $543K for 3,505 services; 2023 $526K for 3,877 services; 2024 $560K for 4,150 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin Pham prescribed most often to Medicare patients was Calcitriol, with 522 prescriptions and refills. In total Kevin Pham wrote 7,059 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Calcitriol Generic | 522 | 1,162 | 130 | $9,030 |
| Furosemide Generic | 442 | 848 | 117 | $1,983 |
| Farxiga Dapagliflozin Propanediol | 353 | 400 | 74 | $216K |
| Kerendia Finerenone | 277 | 289 | 38 | $181K |
| Sevelamer Carbonate Generic | 252 | 468 | 70 | $79K |
| Hydralazine Hcl Generic | 244 | 491 | 76 | $3,448 |
| Metoprolol Tartrate Generic | 219 | 524 | 65 | $1,752 |
| Amlodipine Besylate Generic | 215 | 534 | 75 | $1,015 |
| Calcium Acetate Generic | 199 | 389 | 62 | $24K |
| Losartan Potassium Generic | 183 | 461 | 62 | $1,875 |
| Lokelma Sodium Zirconium Cyclosilicate | 170 | 183 | 33 | $104K |
| Veltassa Patiromer Calcium Sorbitex | 163 | 176 | 39 | $139K |
| Nifedipine Er Nifedipine | 146 | 330 | 36 | $4,970 |
| Sodium Polystyrene Sulfonate Generic | 144 | 214 | 60 | $8,975 |
| Potassium Chloride Generic | 130 | 251 | 40 | $2,128 |
Brand drugs: 1,942 claims; generic drugs: 5,091 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin Pham $4,143 ($4,143 in general payments such as food, travel and fees) from 21 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $712.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 26 | $712 |
| Travere Therapeutics, Inc. TVTX | 18 | $475 |
| Ardelyx, Inc. ARDX | 19 | $430 |
| Mallinckrodt Hospital Products Inc. | 17 | $336 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 9 | $251 |
| Akebia Therapeutics Inc AKBA | 10 | $242 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $224 |
| Fresenius USA Marketing, Inc. | 10 | $214 |
| Calliditas Therapeutics US Inc. | 6 | $177 |
| Apellis Pharmaceuticals, Inc. APLS | 6 | $151 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.